Phase I Trial Results for Liver Perfusion with Oxaliplatin
Puerto Rico, February 24-27
Zeh H: Phase I Trial Results for Liver Perfusion with Oxaliplatin. Second International Symposium on regional Cancer Therapies. Puerto Rico, February 24-27, 2007.
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
Bartlett DL, Libutti SK, Figg WD, et al.: Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001;129:176-187.
Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to the liver
Alexander HR, Libutti SK, Pingpank JF, et al.: Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to the liver. Clin Cancer Res 2003;9: 6343-6349.
Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms
Grover Ac, Libutti Sk, Pingpank JF, et al.: Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. Surgery 2004;136:1176-1182.
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
Libutti SK, Bartlett DL, Fraker DL, et al.: Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 2000;191:519-530.